PharmaShots | Incisive News in 3 Shots

Subscribe Now

tumor

Merck Receives the US FDA's Priority Review for Keytruda's (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type

Merck Receives the US FDA's Priority Review for Keytruda's (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type

April 7, 2020

Zai Lab and Novocure's Optune Receive NMPA's Innovative Medical Device Designation for its Tumor Treating Field Delivery System

Zai Lab and Novocure's Optune Receive NMPA's Innovative Medical Device Designation for its Tumor Treating Field Delivery System

August 12, 2019

Regeneron to Present Results of Libtayo (cemiplimab) for Six Tumor Indications at ESMO 2018

Regeneron to Present Results of Libtayo (cemiplimab) for Six Tumor Indications at ESMO 2018

October 9, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us